Trial Profile
Fampridine treatment to improve fatigue in Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Mar 2021
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms FAMP-MS
- 05 Mar 2021 Status changed from not yet recruiting to completed.
- 16 Aug 2011 New trial record